Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Haeberlein Samantha L. Budd | Director | 2024-12-19 | 12,000 | $1.71 | $20.52kBuy |
Ivana Magovcevicliebisch | President and CEO | 2024-12-19 | 5,000 | $1.68 | $8.40kBuy |
Ivana Magovcevicliebisch | President and CEO | 2024-12-18 | 5,000 | $1.67 | $8.35kBuy |
Ivana Magovcevicliebisch | President and CEO | 2024-12-05 | 5,000 | $2.34 | $11.70kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Bruce Booth | 12.52% | 5,841,874 | $45.92M | Insider |
Atlas Venture Fund XII LP | 12.51% | 5,836,874 | $45.88M | Insider |
Atlas Venture Life Science Advisors LLC | 12.51% | 5,836,874 | $45.88M | Institution |
Stefan Vitorovic | 10.78% | 5,032,465 | $39.56M | Insider |
Vida Ventures GP III LLC | 10.75% | 5,015,929 | $39.43M | Insider |
Northpond Ventures GP LLC | 9.03% | 4,214,498 | $33.13M | Insider |
Bvf Inc | 8.60% | 4,013,633 | $31.55M | Institution |
Amgen Inc | 6.87% | 3,206,281 | $25.20M | Insider |
Siren LLC | 4.21% | 1,967,064 | $15.46M | Institution |
683 Capital Management LLC | 3.73% | 1,740,000 | $13.68M | Institution |